These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 37026262)
21. Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis. Toda I; Ide T; Fukumoto T; Ichihashi Y; Tsubota K Am J Ophthalmol; 2014 Mar; 157(3):616-22.e1. PubMed ID: 24528935 [TBL] [Abstract][Full Text] [Related]
22. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition. Shigeyasu C; Yamada M; Akune Y; Tsubota K Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103 [TBL] [Abstract][Full Text] [Related]
23. Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis. Mori Y; Nejima R; Masuda A; Maruyama Y; Minami K; Miyata K; Amano S Cornea; 2014 Jul; 33(7):659-62. PubMed ID: 24858017 [TBL] [Abstract][Full Text] [Related]
24. Combination Therapy With Diquafosol Sodium and Sodium Hyaluronate in Eyes With Dry Eye Disease After Small Incision Lenticule Extraction. Liu Y; Qian Y; Li M; Shi Y; Liu L; Sun L; Ye H; Zou J In Vivo; 2023; 37(6):2829-2834. PubMed ID: 37905613 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials. Wu D; Chen WQ; Li R; Wang Y Cornea; 2015 Jun; 34(6):644-50. PubMed ID: 25909234 [TBL] [Abstract][Full Text] [Related]
26. Changes in Human Tear Proteome Following Topical Treatment of Dry Eye Disease: Cyclosporine A Versus Diquafosol Tetrasodium. Ji YW; Kim HM; Ryu SY; Oh JW; Yeo A; Choi CY; Kim MJ; Song JS; Kim HS; Seo KY; Kim KP; Lee HK Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):5035-5044. PubMed ID: 31800960 [TBL] [Abstract][Full Text] [Related]
27. Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye. Li L; Jin R; Li Y; Yoon HS; Yoon HJ; Yoon KC Cutan Ocul Toxicol; 2021 Dec; 40(4):350-358. PubMed ID: 34496685 [TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of pilocarpine, cevimeline, and diquafosol compared to artificial tears for the treatment of dry eye: protocol for a systematic review. Serrano-Robles JG; Pérez Vázquez AK; Navas A; Graue-Hernandez EO; Ramirez-Miranda A; Kahuam-López N Syst Rev; 2022 May; 11(1):105. PubMed ID: 35643581 [TBL] [Abstract][Full Text] [Related]
29. A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery. Kim S; Shin J; Lee JE Sci Rep; 2021 Apr; 11(1):9124. PubMed ID: 33907267 [TBL] [Abstract][Full Text] [Related]
30. Effects of Diquafosol Sodium Ophthalmic Solution on Tear Film Matrix Metallopeptidase-9 and Corneal Nerve Density in Patients with Type 2 Diabetic Dry Eye. Qin G; Chen J; Li L; Qi Y; Chen Y; Zhang Q; Wu Y; You Y; Yang L; Guo N; Moutari S; Bu S; Moore JE; Xu L; He W; Yu S; He X; Pazo EE J Ocul Pharmacol Ther; 2024; 40(6):370-378. PubMed ID: 38100078 [No Abstract] [Full Text] [Related]
31. Autologous Serum Eye Drops versus Artificial Tear Drops for Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Wang L; Cao K; Wei Z; Baudouin C; Labbé A; Liang Q Ophthalmic Res; 2020; 63(5):443-451. PubMed ID: 31884498 [TBL] [Abstract][Full Text] [Related]
32. Diquafosol ophthalmic solution 3 %: a review of its use in dry eye. Keating GM Drugs; 2015 May; 75(8):911-22. PubMed ID: 25968930 [TBL] [Abstract][Full Text] [Related]
33. Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye. Shimazaki-Den S; Iseda H; Dogru M; Shimazaki J Cornea; 2013 Aug; 32(8):1120-5. PubMed ID: 23635860 [TBL] [Abstract][Full Text] [Related]
34. Diquafosol ophthalmic solution for dry eye treatment. Nakamura M; Imanaka T; Sakamoto A Adv Ther; 2012 Jul; 29(7):579-89. PubMed ID: 22843206 [TBL] [Abstract][Full Text] [Related]
35. Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye. Cui L; Li Y; Lee HS; Yang JM; Choi W; Yoon KC Int Ophthalmol; 2018 Oct; 38(5):2021-2030. PubMed ID: 28822028 [TBL] [Abstract][Full Text] [Related]
36. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479 [TBL] [Abstract][Full Text] [Related]
37. Randomized Controlled Study to Investigate the Effect of Topical Diquafosol Tetrasodium on Corneal Sensitivity in Short Tear Break-Up Time Dry Eye. Kaido M; Kawashima M; Shigeno Y; Yamada Y; Tsubota K Adv Ther; 2018 May; 35(5):697-706. PubMed ID: 29671255 [TBL] [Abstract][Full Text] [Related]
38. Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study. Kamiya K; Nakanishi M; Ishii R; Kobashi H; Igarashi A; Sato N; Shimizu K Eye (Lond); 2012 Oct; 26(10):1363-8. PubMed ID: 22878452 [TBL] [Abstract][Full Text] [Related]
39. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527 [TBL] [Abstract][Full Text] [Related]
40. Sodium hyaluronate in the treatment of dry eye after cataract surgery: a meta-analysis. Wen Y; Zhang X; Chen M; Han D Ann Palliat Med; 2020 May; 9(3):927-939. PubMed ID: 32434354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]